Azaindazole compounds as CCR1 receptor antagonists

Details for Australian Patent Application No. 2009296839 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Cook, Brian Nicholas; Disalvo, Darren; Fandrick, Daniel Robert; Harcken, Christian; Kuzmich, Daniel; Lee, Thomas Wai-Ho; Liu, Pingrong; Lord, John; Mao, Can; Neu, Jochen; Raudenbush, Brian Christopher; Razavi, Hossein; Reeves, Jonathan Timothy; Song, Jinhua J.; Swinamer, Alan David; Tan, Zhulin

Agent Spruson & Ferguson

Pub. Number AU-A-2009296839

PCT Pub. Number WO2010/036632

Priority 61/100,401 26.09.08 US

Filing date 22 September 2009

Wipo publication date 1 April 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/036632 Priority application(s): WO2010/036632

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296846-Pressure relieving transition joint

2009296838-Sulfonyl compounds which selectively modulate the CB2 receptor